IDEAYA Biosciences (IDYA) Receivables - Net (2020 - 2024)
IDEAYA Biosciences (IDYA) has disclosed Receivables - Net for 5 consecutive years, with $3000.0 as the latest value for Q4 2024.
- Quarterly Receivables - Net fell 83.33% to $3000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Dec 2024, down 83.33% year-over-year, with the annual reading at $3000.0 for FY2024, 83.33% down from the prior year.
- Receivables - Net hit $3000.0 in Q4 2024 for IDEAYA Biosciences, down from $20000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $6.7 million in Q3 2023 to a low of $1000.0 in Q2 2024.
- Historically, Receivables - Net has averaged $1.2 million across 5 years, with a median of $468000.0 in 2023.
- Biggest five-year swings in Receivables - Net: surged 238.8% in 2022 and later crashed 99.7% in 2024.
- Year by year, Receivables - Net stood at $1.9 million in 2020, then tumbled by 41.24% to $1.1 million in 2021, then crashed by 80.87% to $211000.0 in 2022, then plummeted by 91.47% to $18000.0 in 2023, then tumbled by 83.33% to $3000.0 in 2024.
- Business Quant data shows Receivables - Net for IDYA at $3000.0 in Q4 2024, $20000.0 in Q3 2024, and $1000.0 in Q2 2024.